Pfizer expects $15B revenue from COVID-19 vaccine

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Pfizer plans to generate $15B in revenue from sales of its COVID-19 vaccine developed together with the German partner BioNTech.

Actual Topics